Rhythm Biosciences Limited (RHY.AX)
AUD 0.08
(-3.53%)
AUD 0.08
(-3.53%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.69 Million AUD | -45.41% |
| 2023 | 3.09 Million AUD | 27.54% |
| 2022 | 2.42 Million AUD | 118.98% |
| 2021 | 1.1 Million AUD | 1008.51% |
| 2020 | 100 Thousand AUD | -90.27% |
| 2019 | 1.02 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 2.42 Million AUD | 0.0% |
| 2024 Q2 | 1.69 Million AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2023 Q4 | 374.89 Thousand AUD | 0.0% |
| 2023 Q2 | 2.72 Million AUD | 0.0% |
| 2023 FY | 3.09 Million AUD | 27.54% |
| 2022 Q2 | 2.42 Million AUD | 0.0% |
| 2022 FY | 2.42 Million AUD | 118.98% |
| 2022 Q4 | 5.44 Million AUD | 0.0% |
| 2021 Q2 | 1.1 Million AUD | 0.0% |
| 2021 FY | 1.1 Million AUD | 1008.51% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2020 Q4 | 100 Thousand AUD | 0.0% |
| 2020 FY | 100 Thousand AUD | -90.27% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 Q3 | - AUD | 0.0% |
| 2019 Q2 | 283.79 Thousand AUD | 0.0% |
| 2019 FY | 1.02 Million AUD | 0.0% |
| 2019 Q4 | 743.82 Thousand AUD | 0.0% |
| 2019 Q3 | - AUD | -100.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Australian Clinical Labs Limited | 689.72 Million AUD | 99.755% |
| BCAL Diagnostics Limited | 3.09 Million AUD | 45.446% |
| Genetic Signatures Limited | 9.76 Million AUD | 82.694% |
| Genetic Technologies Limited | 7.66 Million AUD | 77.949% |
| Healius Limited | 1.74 Billion AUD | 99.903% |
| Imagion Biosystems Limited | 1.36 Million AUD | -23.596% |
| Integral Diagnostics Limited | 469.69 Million AUD | 99.64% |
| INOVIQ Ltd | 535.11 Thousand AUD | -215.845% |
| Microba Life Sciences Limited | 12.09 Million AUD | 86.02% |
| Monash IVF Group Limited | 254.96 Million AUD | 99.337% |
| Sonic Healthcare Limited | 8.93 Billion AUD | 99.981% |